These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1446053)

  • 1. Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia.
    Paradiso A; Mangia A; Correale M; Abbate I; Ferri G; Piffanelli A; Catozzi L; Amadori D; Riccobon A; De Lena M
    Breast Cancer Res Treat; 1992; 23(1-2):63-70. PubMed ID: 1446053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.
    Brouillet JP; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H
    Eur J Cancer; 1990 Apr; 26(4):437-41. PubMed ID: 2141510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
    Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
    Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between cathepsin-D and other prognostic factors in human breast cancer.
    Glikman P; Rogozinski A; Mosto J; Pollina A; Garbovesky C; Levy C
    Tumori; 1997; 83(3):685-8. PubMed ID: 9267489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.
    Veneroni S; Daidone MG; Di Fronzo G; Cappelletti V; Amadori D; Riccobon A; Paradiso A; Correale M; Silvestrini R
    Breast Cancer Res Treat; 1993; 26(1):7-13. PubMed ID: 8400325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cathepsin D in primary ovarian cancer.
    Scambia G; Panici PB; Ferrandina G; Salerno G; D'Agostino G; Distefano M; de Vincenzo R; Ercoli A; Mancuso S
    Eur J Cancer; 1994; 30A(7):935-40. PubMed ID: 7946587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosol cathepsin D in Thai women with breast cancer.
    Chearskul S; Bhothisuwan K; Tunsuphasiri V; Churinthrapun M; Keyanond V; Ornrheabroi S
    J Med Assoc Thai; 1996 Oct; 79(10):654-60. PubMed ID: 8997001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer.
    Rodríguez J; Vázquez J; Corte MD; Lamelas M; Bongera M; Corte MG; Alvarez A; Allende M; Gonzalez L; Sánchez M; Vijande M; Garcia Muñiz J; Vizoso F
    Int J Biol Markers; 2005; 20(2):103-11. PubMed ID: 16011040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.
    Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H
    Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
    Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
    Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
    Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
    Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer.
    Manuel Del Casar J; Vizoso FJ; Abdel-Laa O; Sanz L; Martín A; Daniela Corte M; Bongera M; García Muñiz JL; Fueyo A
    J Surg Oncol; 2004 Apr; 86(1):16-21. PubMed ID: 15048675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.
    Ferrandina G; Scambia G; Fagotti A; D'Agostino G; Benedetti Panici P; Carbone A; Mancuso S
    Br J Cancer; 1998 Dec; 78(12):1645-52. PubMed ID: 9862578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients.
    Liebert A; Quietzsch D; Beier L
    Anticancer Res; 1999; 19(4A):2571-6. PubMed ID: 10470197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay.
    Roger P; Montcourrier P; Maudelonde T; Brouillet JP; Pages A; Laffargue F; Rochefort H
    Hum Pathol; 1994 Sep; 25(9):863-71. PubMed ID: 8088760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of steroid receptors, pS2 and cathepsin D on the outcome of N+ postmenopausal breast cancer patients treated with tamoxifen.
    Dittadi R; Biganzoli E; Boracchi P; Salbe C; Mione R; Gatti C; Gion M
    Int J Biol Markers; 1998; 13(1):30-41. PubMed ID: 9681297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx.
    Marsigliante S; Biscozzo L; Resta L; Leo G; Mottaghi A; Maiorano E; Colucci G; Storelli C
    Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):51-5. PubMed ID: 9135974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical significance of cathepsin D in breast cancer metastasis.
    Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
    Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of cytosolic concentrations of ER, PS2, Cath-D, TPS, TK and cAMP in primary breast carcinomas.
    Kausitz J; Kuliffay P; Pecen L; Eben K; Puterová B
    Neoplasma; 1994; 41(6):331-6. PubMed ID: 7870216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.